Cleared Traditional

iC-GPC Assay TM for use on the iC-SystemTM

K163390 · Icubate, Inc. · Microbiology
Aug 2017
Decision
249d
Days
Class 2
Risk

About This 510(k) Submission

K163390 is an FDA 510(k) clearance for the iC-GPC Assay TM for use on the iC-SystemTM, a Gram-positive Bacteria And Their Resistance Markers (Class II — Special Controls, product code PAM), submitted by Icubate, Inc. (Huntsville, US). The FDA issued a Cleared decision on August 8, 2017, 249 days after receiving the submission on December 2, 2016. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3365.

Submission Details

510(k) Number K163390 FDA.gov
FDA Decision Cleared SESE
Date Received December 02, 2016
Decision Date August 08, 2017
Days to Decision 249 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PAM — Gram-positive Bacteria And Their Resistance Markers
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3365
Definition A Qualitive Multiplexed In Vitro Diagnostic Device To Detect And Identify Gram Positive Bacteria And Resistant Markers In Positive Blood Cultures.

Similar Devices — PAM Gram-positive Bacteria And Their Resistance Markers

LIAISON PLEX Gram-Positive Blood Culture Assay
K243490 · Luminex Corporation · Jun 2025
ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel
K181663 · Genmark Diagnostics, Incorporated · Dec 2018
Great Basin Staph ID/R Blood Culture Panel
K152470 · Great Basin Scientific, Inc. · Mar 2016
VERIGENE GRAM-POSITIVE BLOOD CULTURE (GC-GP) NUCLEIC ACID TEST
K122514 · Nanosphere, Inc. · Sep 2012
VERIGENE GRAM POSITIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GP)
DEN120014 · Nanosphere, Inc. · Jun 2012